e-Article
Treatment of non-constipated irritable bowel syndrome with the histamine 1 receptor antagonist ebastine: a randomised, double-blind, placebocontrolled trial.
Document Type
Article
Author
Source
Gut; Mar2024, Vol. 73 Issue 3, p459-469, 11p
Subject
Language
ISSN
00175749